MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
2.992 |
Evidence |
|
CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
TP53 |
TP53, P53: Cellular tumor antigen p53 |
2.992 |
Evidence |
|
MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
NEDD4 |
NEDD4: Uncharacterized protein NEDD4 |
2.992 |
Evidence |
|
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
2.992 |
Evidence |
|
HCK |
IPI00029769 |
RAC1 |
IPI00219675 |
2.992 |
Evidence |
|
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
SH3PX3 |
SH3PX3, DKFZp666B159, hCG_1731072: SH3 and PX domain-containing protein 3. |
2.992 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
CAMKK1 |
IPI00166909 |
2.992 |
Evidence |
|
MAX |
MAX: Protein max |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.992 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
2.992 |
Evidence |
|
TCEA1 |
IPI00333215 |
CPSF1 |
CPSF1, CPSF160: Cleavage and polyadenylation specificity factor subunit 1 |
2.992 |
Evidence |
|
CDK6 |
CDK6: Cell division protein kinase 6 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
2.992 |
Evidence |
|
SVIL |
SVIL: Supervillin |
APC |
IPI00215877 |
2.992 |
Evidence |
|
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.992 |
Evidence |
|
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
PURB |
PURB: Transcriptional activator protein Pur-beta |
2.992 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
2.992 |
Evidence |
|
MAP2K3 |
IPI00218858 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
2.992 |
Evidence |
|
GEMIN5 |
GEMIN5: Gem-associated protein 5 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
2.992 |
Evidence |
|
ADK |
ADK: Adenosine kinase |
ARHGEF7 |
IPI00449908 |
2.992 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
2.992 |
Evidence |
|
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
SEC13L1 |
IPI00375370 |
2.992 |
Evidence |
|
LIG1 |
LIG1: DNA ligase 1 |
CDC2 |
CDC2: Cell division control protein 2 homolog |
2.992 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
2.992 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
CDC2L5 |
CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 |
2.992 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SETD3 |
SETD3, C14orf154: SET domain-containing protein 3 |
2.992 |
Evidence |
|
DLG1 |
IPI00218729 |
EPB41L1 |
EPB41L1, KIAA0338: Band 4.1-like protein 1 |
2.992 |
Evidence |
|